Quote:
|
the cost of heathcare (especially in countries with Universal healthcare) will offset the loss of revenue's that treatment would generate.
|
That's what I'm betting on. In the UK, the NHS is the major buyer of pharmaceutical products and as such can exert considerably more pressure on pharmaceutical companies, much more than collections of individuals can. State healthcare also means the State can also to some extent control the sort of research carried out. There's a reason islet replacement therapy and stem cell research are more advanced in the UK and Canada than anywhere else in the world.
